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Mammalian genetic approaches to study gene function have been hampered by the lack of tools to generate stable loss-of-function phenotypes efficiently. We report here a new vector system, named pSUPER, which directs the synthesis of small interfering RNAs (siRNAs) in mammalian cells. We show that siRNA expression mediated by this vector causes efficient and specific down-regulation of gene expression, resulting in functional inactivation of the targeted genes. Stable expression of siRNAs using this vector mediates persistent suppression of gene expression, allowing the analysis of loss-of-function phenotypes that develop over longer periods of time. Therefore, the pSUPER vector constitutes a new and powerful system to analyze gene function in a variety of mammalian cell types.
In several organisms, introduction of doublestranded RNA has proven to be a powerful tool to suppress gene expression through a process known as RNA interference (1) . However, in most mammalian cells this provokes a strong cytotoxic response (2) . This non-specific effect can be circumvented by use of synthetic short [21-to 22-nucleotide(nt) interfering RNAs (siRNAs)], which can mediate strong and specific suppression of gene expression (3) . However, this reduction in gene expression is transient, which severely restricts its applications.
To overcome this limitation, we designed a mammalian expression vector that directs the synthesis of siRNA-like transcripts [pSUPER, suppression of endogenous RNA, Fig. 1A and Supplementary fig. 1C (4) ]. We used the polymerase-III H1-RNA gene promoter, as it produces a small RNA transcript lacking a polyadenosine tail and has a well-defined start of transcription and a termination signal consisting of five thymidines in a row (T5). Most important, the cleavage of the transcript at the termination site is after the second uridine (5) yielding a transcript resembling the ends of synthetic siRNAs, which also contain two 3' overhanging T or U nucleotides (nt) (Fig. 1A) . We designed the gene-specific insert such that it specifies a 19-nt sequence derived from the target transcript, separated by a short spacer from the reverse complement of the same 19-nt sequence. The resulting transcript is predicted to fold back on itself to form a 19 -base pair stem-loop structure, resembling that of C. elegans Let-7 (Fig. 1A) . We used the pSUPER vector to suppress the endogenous CDH1 gene, an activator of the anaphase-promoting complex (APC). We designed three related vectors directing the synthesis of the same 19 -base pair doublestranded CDH1 target sequence, containing loops of seven, nine, or five nucleotides (Fig.  1A , constructs A, B, and C, respectively). We compared the ability of these vectors to inhibit CDH1 to that of synthetic siRNA oligonucleotides targeted against the same sequence of CDH1 (Fig. 1A) in a transient expression experiment in MCF-7 cells. Introduction of CDH1 synthetic siRNA resulted in a reproducible reduction of more than 90% of CDH1 protein (Fig. 1B, lane 2) . Importantly, pSUPER-CDH1-B was able to knockdown CDH1 expression to the same extent as was seen with the synthetic CDH1 siRNA (Fig.  1B, lane 5) . pSUPER-CDH1-A only had a moderate activity, whereas pSUPER-CDH1-C was inactive in this assay, indicating that the size and nucleotide sequence of the loop is very important. Neither the transfection of the synthetic CDH1 siRNA, nor introduction of the siRNA expression vector, had any detrimental effect on cell survival or cell-cycle profile (6) .
Next, we examined whether pSUPER vectors produce siRNA. Northern blot analysis revealed that cells transfected with pSU-PER-CDH1-B produce both sense and antisense 21-to 22-nt CDH1 RNAs, which are similar in size to those seen in cells transfected with the synthetic siRNA (Fig. 1C) . The 49-nt precursor transcript can be barely detected with both probes, suggesting rapid cleavage to siRNA. (Owing to its strong secondary structure, the precursor transcript migrates around 40-nt.) These results indicate that the stem-loop precursor transcript was generated and cleaved in the cell to produce a functional siRNA.
To examine the specificity of our pSU-PER system, we constructed two CDH1 vectors harboring a mutation at either position 2 or 9 of the CDH1 target recognition sequence ( Fig. 2A) . Transient transfection of these constructs into cells failed to suppress CDH1 expression, although both vectors yielded transcripts of the length of siRNAs [ Fig. 2A and (6)]. These results demonstrate that suppression of gene expression by pSUPER system is highly target sequence-specific.
To further test the vector system, we designed both a synthetic siRNA and a pSUPER vector that target the same 19-nt sequence in the CDC20 transcript. As for CDH1, efficient suppression of endogenous CDC20 expression was achieved with both synthetic siRNA and with pSUPER-CDC20 (Fig. 2B) . To measure the level of gene suppression accurately by the pSUPER system, we designed a construct to target polo like kinase-1 (PLK1). Introduction of pSUPER-PLK1 led to a significant decrease in PLK1 protein levels and a reduction in PLK1 kinase activity by a factor of 10 [Supplementary fig. 1A (4) ]. To date, we were successful in knocking down the expression of more than 10 genes for which we designed a pSUPER siRNA vector, highlighting the efficiency with which genes can be targeted using this vector (6) .
Next, we asked whether suppression of gene The H1-RNA promoter was cloned in front of the gene specific targeting sequence (19-nt sequences from the target transcript separated by a short spacer from the reverse complement of the same sequence) and five thymidines ( T5) as termination signal. The predicted secondary structures of pSUPER-CDH1 transcripts and the synthetic siRNA used to target CDH1 are depicted. (B) MCF-7 cells were transfected using an electroporation protocol, which results in more than 90% transfection efficiency (7). The indicated DNA constructs (1 g) and synthetic siRNA (1.5 g) were transfected.
Sixty hours later whole-cell extracts were prepared, separated on 10% SDSpolyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotted to detect CDH1 protein. An immunoblot with antibody against cyclin D1 was used as a control. (C) Cells were transfected as described above, and total RNA was extracted 60 hours later. RNA (30 g) was loaded on an 11% denaturing polyacrylamide gel, separated, and blotted as described (8) . Membranes were probed with either 32 P-labeled sense or antisense 19-nt Cdh1 target oligonucleotide and visualized by PhosphorImager (overnight exposure). The stem-loop precursor and the siRNAs are indicated. The control 5S-rRNA band was detected with ethidium bromide staining. (D) Left, Cells were transfected with increasing amounts pSUPER-p53, which is predicted to produce the depicted transcript. Sixty hours after transfection cells were either irradiated (ϩIR, 20 Gy) or left untreated, harvested 2 hours later, and separated on 10% SDS-PAGE. Immunoblot with p53-specific antibody was preformed and the bands corresponding to p53 protein and a loading control are indicated. Middle, Northern blot showing levels of p53 mRNA in cells transfected with 1 g of pSUPER constructs as indicated. Ethidium bromide staining of rRNAs is used as loading control. Right, Flow cytometry was performed on cells transfected with 1 g plasmids 24 hours after irradiation as described (7 ). Cells with DNA in the G 1 phase are indicated with an arrow.
expression by the pSUPER vector is sufficient to affect cellular physiology. We designed a construct to knockdown p53, a transcription factor that is stabilized following ionizing radiation (IR) and plays a crucial role in the maintenance of cell-cycle arrest in G 1 after DNA damage (7). Transfection of pSUPER-p53 reduced endogenous and overexpressed p53 protein [Fig. 1D , left, and Supplementary fig. 1B (4) ] to very low levels and prevented entirely its induction after IR (Fig. 1D, left) . Suppression of p53 was at the mRNA level, which was reduced by at least 90%, as judged by PhosphorImager quantification (Fig. 1D, middle) . When vector-transfected cells were irradiated, they arrested within 24 hours in either G 1 or G 2 with very few cells remaining in S phase (Fig. 1D, right) . In contrast, cells transfected with the pSUPER-p53 almost completely lost their p53-dependent arrest in G 1 but were able to establish a p53-independent G 2 /M arrest. These results indicate that our vector can suppress endogenous p53 expression to the extent that it completely abrogates its function in the DNA damage response.
Finally, we asked whether the pSUPER vector can mediate stable suppression of gene expression. MCF-7 cells were co-transfected with a vector containing the puromycin-resistance marker and either pSUPER or pSUPER-p53. Cells were selected with puromycin, and resistant clones were cultured. When analyzed after 2 months, all pSUPER-transfected control clones stained brightly with p53-specific antibody, whereas more than 50% of pSUPER-p53 transfected clones showed significant reduction in p53 level (Fig. 3, A and B) . In these stable clones p53-specific siRNA production was clearly detected (Fig. 3C, lanes 2 and 3) and was comparable to the level obtained after transient transfection of pSUPER-p53 (lane 1). These results indicate that the knockdown mediated by pSUPER is maintained over long periods and that its transcript products are not toxic to cells, as no selection against p53 knockdown was observed.
In summary, we provide a powerful new tool to stably suppress gene expression in mammalian cells, which will be useful in a variety of biological systems. Our finding that a single nucleotide mismatch in the 19-nt targeting sequence abrogates the ability to suppress gene expression also opens new avenues for gene therapy. Vectors that target disease-derived transcripts with point mutations, such as those from mutant RAS or TP53 oncogenes, can now be specifically designed, without altering the expression of the remaining wild-type allele. In addition it should be possible to generate large collections of pSUPER siRNA vectors to carry out high-throughput genetic screens for loss-offunction phenotypes.
Fig. 2. (A) An intact target recognition sequence is required to suppress CDH1 by pSUPER-CDH1
vector. The CDH1 19-nt target-recognition sequence was mutated to give a 1-base pair substitution at either position 9 or 2 of the stem. The predicted secondary structures of the transcripts are shown. U2OS cells were transfected exactly as described in Fig. 1 . Whole-cell extracts were prepared after 60 hours, separated on 10% SDS-PAGE, and analyzed by immunoblotting with CDH1-specific antibody. Cyclin D1 protein was used to demonstrate equal loading. (B) Suppression of CDC20 expression by both synthetic siRNA and pSUPER-CDC20. Shown are the sequences of the siRNA and the predicted transcript of pSUPER-CDC20 utilized to knockdown CDC20 expression. The indicated siRNAs and plasmids were transfected into MCF-7 cells as described above. Whole-cell extracts were separated on 10% SDS-PAGE and immunoblotted to detect CDC20 and cyclin D1 proteins. Two transfections from each vector are shown. CD1d-restricted autoreactive natural killer (NK1.1 ϩ ) T cells function as regulatory cells in various disease conditions. Using improved tetramer tracking methodology, we identified a NK1.1 -thymic precursor and followed its differentiation and emigration to tissues by direct cell transfer and in situ cell labeling studies. A major lineage expansion occurred within the thymus after positive selection and before NK receptor expression. Surprisingly, cytokine analysis of the developmental intermediates between NK Ϫ and NK ϩ stages showed a T helper cell T H 2 to T H 1 conversion, suggesting that the regulatory functions of NK T cells may be developmentally controlled. These findings characterize novel thymic and postthymic developmental pathways that expand autoreactive cells and differentiate them into regulatory cells.
In addition to mainstream CD4 and CD8 ␣␤ T cells, the thymus produces specialized subsets of autoreactive regulatory cells, including CD1d-restricted CD4 ϩ and CD4 
CD25
ϩ cells. These cells exist at relatively high frequencies in peripheral tissues, where they regulate conventional T cell responses through the secretion of cytokines such as interleukin-4 (IL-4), IL-10, transforming growth factor-␤, or interferon-␥ (IFN-␥) [reviewed in (1, 2) ]. Although little is known about the steps that govern the development of these cells, the study of T cell receptor ( TCR) transgenic models has shown that the autoreactive nature of their TCRs is essential for their differentiation into regulatory cells (3, 4) . However, direct study of the development of natural, nontransgenic regulatory cells has not been feasible because of their rarity and the lack of specific markers.
We focused on the developmental steps of the major population of regulatory NK T cells, which express the conserved V␣14-J␣18/V␤8 TCR ( V␣24-J␣18/V␤11 in humans), and which regulate a broad range of disease conditions such as type I diabetes, cancer, and infections [reviewed in (5, 6) ]. The development of these cells is particularly intriguing because they are a hybrid of the T and NK lineages, expressing both the ␣␤ TCR and the inhibitory MHCspecific NK receptors (5, 6) . Previous studies have shown that, unlike other autoreactive T cells, autoreactive NK T cells are not deleted in the thymus but are positively selected upon recognition of CD1d ( presumably with an endogenous ligand) expressed by CD4 ϩ 8 ϩ cortical thymocytes (7, 8) . The inherent autoreactivity of NK T cells seems to be controlled by the inhibitory NK receptors, because it is revealed in hybridomas lacking these NK receptors and in fresh cells exposed to dendritic cells (DCs) lacking the classical MHC class I ligands of these NK receptors (9, 10) .
To study the developmental branchpoints of NK T cells relative to the T and NK lineages, the acquisition of T H 1 or T H 2 profiles, and the mechanisms underlying their high frequency in tissues, we identified these cells using tetramers of CD1d loaded with the synthetic lipid ␣-galactosylceramide (␣GC). CD1d-␣GC tetramers uniformly stain all NK T cells expressing the V␣14-J␣18/V␤8 TCR (11, 12) . Because NK T cells are rare, nonspecific background staining is a problem; this can be partly overcome by simultaneous staining with empty CD1d tetramers (referred to as CD1d) conjugated with a different fluorochrome. After gating on CD1d-␣GC ϩ
CD1d
Ϫ thymocytes of 2-week-old B6 mice, the proportions of cells found were 0.08% in wildtype mice versus Ͻ0.01% in control J␣18 -/-mice (13) lacking NK T cells (Fig. 1A) (14) . Nearly all of the cells were found among CD8 Ϫ thymocytes expressing low levels of the early cell surface marker HSA, whereas the few CD8 ϩ cells were HSA high and indistinguishable from background (as measured in J␣18 Ϫ/Ϫ ). By focusing on these HSA low cells in 2-week-old mice, we observed a predominance of NK1.1 Ϫ cells, as reported by others (15) , in contrast to the predominantly NK.1.1 ϩ phenotype of their adult counterparts (Fig. 1B) . Other NK lineage receptors (such as Ly49A, Ly49G/I, Ly49C, and CD94/NKG2) were also expressed late, along with or after NK1.1 (15, 16) .
In situ labeling of thymocytes with fluorescein isothiocyanate (FITC) allowed the identification of recent emigrants in the spleen and liver (17) . At 24 hours, most of these emigrants failed to express NK lineage markers and had the same CD44 high NK1.1 Ϫ phenotype as the thymic pre-NK1.1 stage ( Fig. 2A) . After 24 hours, a progressive expression of NK1.1 was observed (Fig. 2, A and B), suggesting that the thymic emigrants acquired the NK phenotype after entry into peripheral sites (18) . The frequency of V␣14 T cells among recent thymic emigrants was conspicuously high, at 4% in Fig. 2A and on average (16), and we estimate that as many as 1 ϫ 10 5 V␣14 T cells could be exported to the spleen every day, a relatively large number compared with the size of the resident NK T population (5 ϫ 10 5 to 10 ϫ 10 5 ) (19) . To directly test the precursor-product relation between NK1.1 Ϫ and NK1.1 ϩ cells, we sorted the NK1.1 Ϫ cells and transferred them intrathymically into J␣18 Ϫ/Ϫ hosts, which lack NK T cell precursors. We mixed into the inoculum 3% congenically marked, sorted NK1.1 ϩ thymocytes (20) to rule out the possibility that a minor population of NK1.1 ϩ contaminants could expand and account for the NK1.1 ϩ cells found later. We found that most of the NK1.1 Ϫ cells expressed NK1.1 within a week, both in the thymus (Fig. 2C ) and in the spleen and liver (16) , whereas the congenically marked contaminants were not detectable. These results show that NK1.1 Ϫ cells represent precursors to those expressing NK1.1.
Because the thymic emigration experiments suggested a major expansion of V␣14 thymocytes before emigration, we examined the cell cycle status and turnover rate of NK T cell developmental intermediates (21) . Indeed, we found that a large fraction of both CD44 
